Ribosomal protein L37 pseudogene 11 (RPL37P11)

Ribosomal protein L37 pseudogene 11 (RPL37P11) is one of many processed pseudogenes related to the gene encoding ribosomal protein L37, a structural component of the 60S subunit of ribosomes. Pseudogenes like RPL37P11 arise from duplication or retrotransposition events of parent ribosomal protein genes, and they do not produce a functional protein product. While in theory pseudogenes may have regulatory or RNA interactions, RPL37P11 itself is not known to have an established biological function, disease association, or relevance as a therapeutic target. Its presence is mainly noted as a genomic feature without currently known clinical or pharmacological implications. The parent gene, RPL37, encodes a ribosomal structural protein involved with the 60S ribosomal subunit, playing a role in protein biosynthesis. There are many pseudogenes for ribosomal proteins since these gene families are large and prone to duplication/retrotransposition events. Pseudogenes are generally not transcribed into functional proteins, though in rare cases they may have regulatory RNA effects, but this is not the case for RPL37P11, as no data support a functional role for this specific pseudogene. If searching for an actionable therapeutic target, RPL37P11 would not be appropriate; investigations should focus on the protein-coding parent gene (RPL37) or other regulatory/protein-coding genes. There is no evidence that RPL37P11 is implicated in any disease, targeted by drugs, or acts as a biomarker or therapeutic target; its identification as a "target" is a misunderstanding of nomenclature.

Other names

RPL37_3_203RPL37P11

None (no known drugs/agents act through this pseudogene)